LATEST

• BUSINESS Taisho, Meiji to Restrict Shipments of Vorzzz 2.5 mg
  December 11, 2025

• BUSINESS Asahi Kasei Pharma Confident of Hitting FY2030 Group Sales Target: President
  December 10, 2025

• BUSINESS Astellas Sees Xtandi Patent Cliff a “Critical Phase,” Steps Up Board Oversight via EPM
  December 10, 2025

• REGULATORY LDP Lawmakers’ League Urges Continued Coverage for Local Transdermal Analgesics
  December 10, 2025

• REGULATORY Senior LDP Lawmakers Call for “Net Plus” in FY2026 Fee, Drug Price Revisions
  December 10, 2025

• BUSINESS PeptiDream Hits Milestone with Asahi Kasei Collaboration
  December 10, 2025

• BUSINESS Eisai’s Leqembi Added to China Commercial Insurance Drug List
  December 10, 2025

• BUSINESS Drug Makers, Wholesalers See No Major Disruptions after Aomori Quake
  December 10, 2025

• BUSINESS SanBio Clears Hurdle for Akuugo Shipments, Heads to Reimbursement Talks
  December 10, 2025

• COMMENTARY FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed
  December 9, 2025

• REGULATORY Japan Govt Council Discusses Draft Recommendations for National MCM Strategy
  December 9, 2025

• BUSINESS Kaken’s Head Lice Lotion Hits PIII Goal, Filing Eyed in 1st Half of FY2026
  December 9, 2025

• REGULATORY MHLW Eyes Govt-Led Ingredient Lists for Regional Formularies: LDP Briefing
  December 9, 2025

• BUSINESS LinqMed Builds Radiopharma Plant in Rare Manufacturing Bet for Biotech Startup
  December 9, 2025

• REGULATORY JMA Pushes Back on Incentives Tied to Regional Formularies: Chuikyo
  December 9, 2025

• BUSINESS Kazuo Nakamura, Founder of Japan’s First CRO, Dies at 78
  December 9, 2025

• BUSINESS Erbitux-Braftovi Combo Now Available for Frontline BRAF-Mutant Colorectal Cancer in Japan
  December 9, 2025

• REGULATORY PMDA to Adopt General-Purpose AI in FY2025, Eyes Specialized Tools for Reviews and Safety Work
  December 8, 2025

• REGULATORY Japan Likely to Extend Generic-Name Prescribing Premium to Biologics to Spur Biosimilars
  December 8, 2025

• REGULATORY Aspirin, CAR-T and Other Products under PMDA Safety Review
  December 8, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• …
• Next ›
• 最終 »